|
|
 |
Editor(s)
Stephanie Ann Gregory, MD
Elodia Kehm Chair of Hematology
Professor of Medicine
Director, Section of Hematology
Rush University Medical Center/Rush University
Chicago, Illinois
Stephanie Ann Gregory, MD holds the Elodia Kehm Chair of Hematology and is professor of medicine and director of the Section of Hematology at Rush University Medical Center/Rush University, Chicago, Illinois. She received her medical degree with honors from The Woman’s Medical College of Pennsylvania in Philadelphia, Pennsylvania. Her postgraduate training included an internship, residency, and chief residency in internal medicine at Rush University Medical Center. She then underwent three years of subspecialty training in hematology with a research grant from the Schweppe Foundation, also at Rush University Medical Center. Dr Gregory is certified by the American Board of Internal Medicine and holds subspecialty certification in hematology.
Dr Gregory’s research interests include Hodgkin and non-Hodgkin lymphomas, leukemias, and myelomas, especially using novel approaches of immunotherapy. She has been involved in several radioimmunotherapy trials in non-Hodgkin lymphoma and is presently involved in many clinical trials with small molecules targeted to malignant lymphoma and leukemia cells. She has chaired or co-chaired several national and international symposia on hematologic malignancies. In September 2008, she was co-chair of the American Society of Hematology State-of-the-Art Symposium. She is the senior author of the fourth edition of the American Society of Hematology Self-Assessment Program Book (ASH-SAP). She has authored or coauthored more than 400 manuscripts, books, book chapters, and abstracts. Dr Gregory speaks extensively on hematologic malignancies both nationally and internationally. In 1994 Dr Gregory worked in Croatia as a member of the United Nations Security Council Commission of Experts investigating war crimes and sexual assaults against women in the former Yugoslavia.
Dr Gregory is a member of the Advisory Boards of the Lymphoma Research Foundation, the Leukemia Research Foundation, and the Leukemia & Lymphoma Society. She is an active member of the American Society of Hematology, American Society of Clinical Oncology, and numerous other medical professional associations.
Dr Gregory’s career has been directed toward patient care, teaching, research, and administration. She was elected to the Mark H. Lepper, M.D. Society of Teachers at Rush Medical College in 1986. She received an endowed chair as Director of Hematology at Rush in 1995. She was elected the first woman president of the Chicago Society of Internal Medicine from 1994 to 1995. She is a fellow of the American College of Physicians, a member of the Northern Illinois Council of the College, and in 1996 received the Illinois Laureate Award from the college. She was awarded the 1998 Alumnae Achievement Award by the Medical College of Pennsylvania/Hahnemann Medical School. She received the Excellence in Medicine Award from the Department of Medicine of Rush University Medical Center in 2006. In 2008, Dr Gregory was awarded the Lymphoma Research Foundation’s Chicago HOPE Award.
Michael Pfreundschuh, MD
Director, Department of Internal Medicine
Professor of Internal Medicine
Saarland University Medical School
Saarbrucken, Germany
Michael Pfreundschuh, MD is director of the Department of Internal Medicine and professor of internal medicine at Saarland University Medical School in Saarbrucken, Germany. Dr Pfreundschuh earned his medical degree at Heidelberg University. He completed his residency at the University of Heidelberg followed by a clinical fellowship at Memorial Hospital and a research fellowship at Memorial Sloan-Kettering Cancer Center in New York. He finished his training in internal medicine and hematology/oncology at Heidelberg University and Hannover Medical School.
Dr Pfreundschuh’s research focuses on tumor immunology, cancer immunotherapy, and lymphoma chemotherapy. He is a founding member and chairman of the German High Grade Non-Hodgkin-Lymphoma Study Group and founding member of the Academy of Cancer Immunology.
Dr Pfreundschuh has received many awards for his work, including the prestigious William B. Coley Award for Distinguished Research in Basic and Tumor Immunology.
|
|
|